Note: As of this writing, CRIO’s Reviewer EDCmodel (eSource/EDC) is live in several studies; early indications are that the new operating model saves sponsors and CROs significant monitoring time. In this post, we outline the current CRA time allocation as a baseline, then model how our innovative approach can cut that time in half. Clinical...
Disclaimer: The examples noted in the following article are all firsthand accounts of the author, but for the purpose of this article have been combined into a single site visit. The visit depicted below is an aggregate of many sites and studies and is not necessarily an exact representation. The original version was written entirely...
CRIO’s integrated eSource-EDC model revolutionizes both the data entry process at the site level and the monitoring process from the CRO perspective. According to a third party survey of CRAs who have used CRIO, CRAs agreed by a margin of 23:1 that this new model would increase overall trial efficiency, improve data quality, and enhance...
The clinical research industry made big changes to adapt to the operational disruptions of a global pandemic. Today, it’s more exciting and diverse than ever before. With the high level of technology adoption to enable the continuity of clinical trials, CRIO wanted to learn more about CRA experiences using the CRIO platform, the leader in eSource technology. CRIO retained...
In a survey commissioned by Clinical Research IO (CRIO), 62% of sites, who mainly conduct non-oncology trials, reported that they use their Electronic Medical Record (EMR) system as their primary system for recruiting patients, but only 13% reported that they use their EMR as their primary system for source data collection. For source data collection,...
Over 13,000 protocols have gone through the CRIO system, and in the vast majority of them, CRAs have used CRIO to monitor source. We’ve always heard from our sites that their CRAs love the system, but now we have proof. According to a third party survey of CRAs who have used CRIO, by a healthy...
73% of sites reported using paper as the primary means of data collection In a 2018 CRIO site survey with over 100 respondents, sites reported that they use their Electronic Medical Record (EMR) primarily for patient recruitment purposes, but not for source data collection. 62% of site respondents reported that they use the EMR as...
The staying power of technology after the pandemic The clinical trials industry has historically been slow to adopt innovation, but 2020 was a catalyst for transformation. Spurred on by the need for business continuity during the pandemic, sites and sponsors worldwide were highly motivated to reconsider business as usual, and many have adopted an array...
In 2020, CRIO more than doubled in revenue and tripled in employees. Periods of rapid growth are high risk and can undermine cohesive work culture. This is even more true when everyone is working remotely, where there is no shared office space to foster social bonding. That’s why I’m proud that in March 2021, CRIO...
